#United States #Kessler Topaz #Radnor #Securities Class #ModivCare

Important Deadline for ModivCare Investors

Investors in ModivCare Inc. (NASDAQ: MODV) are facing a critical deadline in a securities class action lawsuit. The suit has been brought against the company by the law firm Kessler Topaz Meltzer & Check, LLP on behalf of individuals who purchased ModivCare securities between November 3, 2022, and September 15, 2024. The deadline for investors to apply for lead plaintiff status is March 31, 2025.

Background of the Case

According to the lawsuit, ModivCare allegedly made false statements and omitted key information about its business operations that misled investors. The complaint specifically outlines several misrepresentations regarding the company's financial health and operational stability. For instance, it claims that ModivCare's non-emergency medical transportation contracts, which were expected to enhance cash flow, actually had a negative impact on the total free cash flow, contradicting the company's public assertions.

Furthermore, it is alleged that the company’s renegotiation of contracts and pricing strategies had adverse effects on its adjusted EBITDA, and that ModivCare was operating with insufficient liquidity at the time. These factors, according to the lawsuit, rendered previous statements made by the company misleading and without a basis of truth.

What Investors Should Know

Leading up to the March 31, 2025 deadline, investors are encouraged to consider their legal options carefully. They may either opt to represent the class as lead plaintiffs or remain absent class members. Taking on the role of a lead plaintiff enables investors to direct the litigation while collaborating with legal counsel. It's typically associated with those who have sustained the largest financial losses related to the case.

For contextual clarity, a lead plaintiff acts as a voice for all involved investors, which means that their experience should ideally match that of the broader class. This means selecting and working with an attorney suited for this representation is crucial, as the court must approve the chosen counsel.

Kessler Topaz Meltzer & Check, LLP urges any investors significantly impacted by losses related to ModivCare's alleged misconduct to reach out for more information on how to proceed with the case.

Contact Information

Now more than ever, it is essential for investors to stay informed and proactive. If you believe you qualify for participation in this class action lawsuit, Kessler Topaz Meltzer & Check, LLP has made it easy to get involved. Interested parties are encouraged to visit their website at www.ktmc.com or contact attorney Jonathan Naji directly at the provided phone number (484) 270-1453 or via email to discuss further steps.

Conclusion

The approaching deadline of March 31, 2025, is a crucial date for affected ModivCare investors. Following updates from Kessler Topaz will be vital as developments continue to unfold. Investors should not delay in contacting legal representation to ensure their voices and claims are adequately heard in the ongoing litigation.